Ruiz-Morales JM, Dorantes-Heredia R, Motola-Kuba D

Language: Spanish
References: 14
Page: 137-140
PDF size: 224.11 Kb.

ABSTRACT

Lung cancer is the first cause of death among cancer patients in the world. Adenocarcinoma is the most frequent histologic subtype of lung cancer. From the different varieties of adenocarcinoma, one of the less frequent subtype is the oncocytic papillary lung cancer. Even though clinical stage at diagnosis is the most important prognostic factor, it has been demonstrated that this subtype has a better prognosis compared to other subtypes of adenocarcinoma, like solid, acinar and micropapillary. It has being recently described an association between oncocytic papillary adenocarcinoma and mutations in the epidermal growth factor receptor, which can be used as a targeted treatment option. We describe two cases of patients with primary oncocytic papillary adenocarcinoma of the lung and their treatment.

REFERENCES

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-36.

2. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med 2008; 359: 1367-80.

3. Kerr KM. Pulmonary adenocarcinomas: classification and reporting. Histopathology 2009; 54: 12-27.

4. Travis W, Brambilla E, Muller-Hermelink H. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press; 2004.

5. Amin MB, Tamboli P, Merchant SH, et al. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol 2002; 26: 358-64.

6. Hayashi Y, Takanashi Y, Ohsawa H, Ishii H, Nakatani Y. Hepatoid adenocarcinoma in the lung. Lung Cancer 2002; 38: 211-4.

7. Kish JK, Ro JY, Ayala AG, McMurtrey MJ. Primary mucinous adenocarcinoma of the lung with signet-ring cells: a histochemical comparison with signet-ring cell carcinomas of other sites. Hum Pathol 1989; 20: 1097-102.

8. Melamed MR. Mucinous (so-called colloid) carcinoma of the lung. Am J Surg Pathol 2004; 28: 1397; author reply.

9. Rossi G, Sartori G, Murer B, Capitanio G, Cavazza A. Mucin-rich tumors of the lung. Am J Clin Pathol 2007; 127: 473-4; author reply 4.

10. Silver SA, Askin FB. True papillary carcinoma of the lung: a distinct clinicopathologic entity. Am J Surg Pathol 1997; 21: 43-51.

11. Solis LM, Raso MG, Kalhor N, Behrens C, Wistuba, II, Moran CA. Primary oncocytic adenocarcinomas of the lung: a clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases. Am J Clin Pathol 2010; 133: 133-40.

12. Tsuta K, Kalhor N, Raso MG, Wistuba, II, Moran CA. Oncocytic neuroendocrine tumors of the lung: histopathologic spectrum and immunohistochemical analysis of 15 cases. Hum Pathol 2011; 42: 578-85.

13. Crino L, Weder W, van Meerbeeck J, Felip E. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl. 5): v103-v115.

14. Tsutaa K, Kawagoa M, Eisuke Inoue, et al. The utility ofthe proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer 2013; 81: 371-6.